PALISADE CAPITAL MANAGEMENT, LP Q4 2019 Filing

Filed February 4, 2020

Portfolio Value

$3.5B

Holdings

410

Report Date

Q4 2019

Filing Type

13F-HR

All Holdings (410 positions)

StockValue
DEODIAGEO P L C
$208K
FEYECHFFIREEYE INC
$182K
—PARATEK PHARMACEUTICALS INC
$164K
—RETROPHIN INC
$163K
CLVSEURCLOVIS ONCOLOGY INC
$146K
NYCBEURNEW YORK CMNTY BANCORP INC
$132K
SENS1GBPSENSEONICS HLDGS INC
$69K
—NANTHEALTH INC
$42K
—ENCORE CAP GROUP INC
$15K
—PALATIN TECHNOLOGIES INC
$15K
PreviousPage 5 of 5